Disclosure
Consultant: Ceregene, Inc.; Novartis/Orion; Abbot/Solvay; Lundbeck; Teva Neuroscience
Speaker: Teva Neuroscience
Stock Options: Ceregene, Inc.
Stock: Clintrex
Biography
Henry P. and Georgette Goldschmidt Professor and Chairman Emeritus,
Department of Neurology,
Director of the Bendheim Parkinson Center,
Mount Sinai School of Medicine,
New York, NY
Dr. Olanow received his medical degree from the University of Toronto, performed his neurology training at the New York Neurological Institute at Columbia University, and did post-graduate studies in neuroanatomy at Columbia University. He served on the faculties of McGill University, Duke University, and the University of South Florida prior to assuming his present position. Dr. Olanow has authored more than 300 publications primarily related to Parkinson's Disease and neurodegeneration. He is past President of the Movement Disorder Society and past Treasurer of the American Neurological Association. He has served on numerous editorial and scientific advisory boards and has lectured at Universities and Conferences throughout the world.
Disclosure
Consultant: Adamas Pharmaceuticals, Inc.; Civitas; Ipsen; Medtronic; NuPathe, Inc.; Teva Neuroscience
Speaker: Teva Neuroscience
Biography
Parker Family Professor of Neurology,
Director of the Parkinson's Disease and Movement Disorders Center,
University of Pennsylvania,
Philadelphia, PA
The Parkinson's Disease and Movement Disorders Center at Penn is one of the largest of its type in the country and has a long track record of achievement in clinical trials and experimental therapeutics. Dr. Stern has authored or co-authored numerous papers on Parkinson's disease and edited or co-edited 8 books. He has served on the Executive Committee of the American Academy of Neurology's Movement Disorders Section and is a member of the American Neurological Association. He has held several leadership positions in the International Movement Disorder Society and is currently President-elect. In addition to serving as institutional investigator for numerous clinical trials, Dr. Stern has been the Principal Investigator or Co-Principal Investigator of many studies related to Parkinson's disease. He serves on numerous consulting boards and has lectured throughout the world on Parkinson's and related disorders.
Disclosure
Research Support: National Institutes of Health (NEI, NINDS, NIA, NICHD); the Michael J. Fox Foundation; Medivation; Neurosearch; Pfizer
Consulting: The United States Food and Drug Administration; the Veteran's Administration and the National Institutes of Health (NINDS); Abbott; Biogen Idec; Boehringer Ingelheim; Ceregene; Civitas; Clintrex; EMD Serono; FoldRx; Genzyme; Impax; Intec; Ipsen; Isis; Lilly; Link Medicine; Lundbeck; Merz; Novartis; Orion; Otsuka; Phytopharm; Prestwick; Schering-Plough; Siena Biotech; Synosia; Solvay; Teva Neuroscience; UCB Pharma; Xenoport
Legal Consulting: Pfizer and the Welding Rod Litigation Defendants
Speaker: Teva Neuroscience
Biography
Professor of Neurology and Community and Preventive Medicine,
Director of the Center for Human Experimental Therapeutics,
University of Rochester Medical Center,
Rochester, NY
Dr. Kieburtz' primary clinical and research interests are in the treatment of neurodegenerative diseases affecting the basal ganglia, particularly Parkinson's Disease, Huntington's Disease, and HIV-related neurologic disorders. He has been an active participant in the research activities of the Parkinson Study Group since 1989, and currently is Chair of the Executive Committee. He is the principal investigator for the NINDS-sponsored program (NET-PD) of neuroprotective agents for PD. He currently serves on the International Executive Committee of the Movement Disorders Society and as Chair of the FDA Peripheral and Central Nervous System Advisory Committee. His publications and presentations have focused on experimental therapeutics and clinical research design strategies.
Disclosure
Consulting/Speaker's Bureau: Boehringer Ingelheim; Clintrex; Glaxo Smithkline; Ipsen; Novartis; Teva Neuroscience; Nupathe, Inc.; Adamas Pharmaceuticals, Inc.; Merz
Biography
Professor of Neurology,
Director of the Movement Disorder Center,
The Medical College of Georgia,
Augusta, GA
Dr. Sethi, who is Board-certified in Neurology and Internal medicine, earned his medical degree at the Christian Medical College, Ludhiana, India. After completing a research fellowship in neurology at the Charing Cross Group of Hospitals and Medical School, London, UK, he was a Registrar in Neurology at the Welsh National School of Medicine at Morriston Hospital, and a Neurology resident at the Medical College of Georgia. Dr. Sethi is a Fellow of the American Academy of Neurology (AAN) and the Royal College of Physicians (London); the Vice President of the Tremor Research Group, and a member of the American Neurological Association (ANA), the Movement Disorder Society (MDS), and the American Association of Physicians from India. Dr. Sethi's research interests are in Parkinson's disease, restless legs syndrome, and cervical dystonia, and he has participated as principal investigator in numerous clinical trial and research studies. An author of numerous reviews, abstracts, book chapters, and journal articles, Dr. Sethi's work has been published in peer-reviewed publications, including Neurology, Movement Disorders and Annals of Neurology. He serves as an editorial reviewer for the journals Movement Disorders, Neurology, Brain, Annals of Neurology and The New England Journal of Medicine, and is a section editor for Current Neurology and Neurosciences Reviews and Medscape Neurology. He has served on the editorial boards of Movement Disorders and AAN.com.